Stay updated on Pembrolizumab in Solid/Micropapillary Lung Adeno Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Solid/Micropapillary Lung Adeno Clinical Trial page.

Latest updates to the Pembrolizumab in Solid/Micropapillary Lung Adeno Clinical Trial page
- CheckyesterdayChange DetectedThe only visible change is the site revision label updating from v3.3.3 to v3.3.4; no study information or page content was altered. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check23 days agoChange DetectedAdded a Locations section with Kangnam as a recruitment site. The previous Kangnam Locations entry is removed and the page revision is updated to v3.3.3.SummaryDifference0.2%

- Check51 days agoChange DetectedThe Publications note was updated to say items are automatically filled from PubMed, and a new revision tag v3.3.2 was added (replacing v3.2.0).SummaryDifference0.1%

- Check58 days agoChange DetectedRemoved the government funding lapse notice about operating status. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check73 days agoChange DetectedThe changes are limited to layout and formatting adjustments; core study details such as inclusion criteria, pembrolizumab treatment, and outcome measures remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check101 days agoChange Detected- Added a government funding lapse notice and operating-status guidance, plus a version bump to v3.2.0. - Removed the old version reference v3.1.0.SummaryDifference3%

Stay in the know with updates to Pembrolizumab in Solid/Micropapillary Lung Adeno Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Solid/Micropapillary Lung Adeno Clinical Trial page.